Tumor necrosis factor (TNFs) have been shown to be synthesized by ovarian carcinomas, and may therefore affect tumor cells in an autocrine manner. Therefore, we investigated the effects of recombinant TNFs on ovarian carcinoma cells N.1 and examined expression of the proto-oncogenes c-myc and cdc25A which are known to play a prominent role in apoptosis.
Introduction
Ovarian carcinoma cells have been shown to produce various cytokines, growth factors and TNFs (Naylor et al, 1993; Wu et al, 1993) which may act as autocrine regulators of cell growth and death. The human ovarian carcinoma cell line N.1 also synthesizes the cytokines IL-1a, IL-6, IL-8 (Harant et al, 1995) and the growth factor M-CSF (Krupitza et al, 1995a) . N.1 cells proved useful for investigating the activity of various differentiating agents, because these cells respond with morphological alterations which accompany growth inhibition (Krupitza et al, 1995b; Grunt et al, 1993) . This property makes it easier to analyze novel compounds and stimuli in a first screen. Moreover, apoptosis, a type of cell death originally defined by its morphology (Kerr, 1971; Wyllie et al, 1980) , has been investigated in N.1 cells during treatment with all-trans retinoic acid, where it was shown that apoptosis of N.1 cells correlated with c-myc expression (Krupitza et al, 1995a,c) .
Since carcinomas frequently over-express the c-Myc transcription factor (Marcu et al, 1992) , attention should be paid to the finding that c-Myc is required for some cells (e.g. Rat1, NIH3T3 and HeLa) to become responsive to TNF (Klefstrom et al, 1994; Janicke et al, 1994) and, therefore, become susceptible to TNF-treatment.
High levels of c-Myc also induce apoptosis of rodent fibroblasts (Evan et al, 1992) and myeloid cells (Askew et al, 1991) under sub-optimal serum conditions. Recently, Galaktionov et al (1996) showed that c-Myc-triggered apoptosis of Rat1-MycER cells was strictly dependent on the expression of Cdc25A, a gene regulating the cell cycle (Jinno et al. 1994) . Moreover, cdc25A induction directly depended on c-Myc nuclear expression. These data suggest a possible link between c-Myc, the cell cycle and apoptosis. Therefore, we investigated the effects of recombinant TNFa on N.1 cells and studied c-myc and cdc25A gene expression, in relation to apoptosis.
We observed that TNF triggered apoptosis of N.1 cells was preceded by Cdc25A down-regulation despite high cMyc expression. c-Myc is responsible for the G 0 to G 1 transition (Marcu et al, 1992) and thus, initiates the cell cycle. Although it was speculated whether subsequent arrest only within a particular phase of the cell cycle might induce apoptosis, the evidence suggests that rodent fibroblasts can undergo apoptosis independent of the cell cycle position (Evan et al, 1992) .
Components of the cell cycle are tightly regulated. In vertebrates the Cdk2-cyclin E complex allows for progression through parts of G 1 into S-phase (for review see McLachlan et al, 1995) . This complex can be inhibited by p27, or when tyrosine 15 of Cdk2 remains phosphorylated (Martin-Castellanos and Moreno, 1997) . De-phosphorylation of Cdk2 tyrosine 15 seems to be a prerequisite for Cdk2 activity (Morgan, 1995) . Specific de-phosphorylation of Cdk2 tyrosine 15 and activation of the Cdk2-cyclin E complex is exerted by the Cdc25A phosphatase (Hofmann et al, 1994) . It is therefore possible, that cdc25A is subjected to rigorous regulation itself, such as by posttranslational activation of Cdc25A by phosphorylation (Galaktionov et al, 1995) .
In the present investigation the expression of genes, which are relevant: (i) for growth and apoptosis such as cMyc (Askew et al, 1991; Evan et al, 1992; Krupitza et al, 1995c) and Cdc25A (Galaktionov et al, 1996) , (ii) for growth arrest such as gas6 (Schneider et al, 1988; Manfioletti et al, 1993) and (iii) for cell cycle progression and G 0 -phase determination such as cyclinD1 (Xiong et al, 1991; Lukas et al, 1994; Resnitzky et al, 1994; Draetta, 1994; Pusch et al, 1996) , was analyzed during apoptotic treatment with TNF. We also addressed the question whether Cdc25A downregulation influenced Cdk2 activity during TNFa induced apoptosis, and how the downregulation of c-Myc affects TNFa-treated cells.
Results

TNFa induces apoptosis in N.1 carcinoma cells
Treatment of N.1 cells with TNFa induced apoptosis dose dependently within 72 h. Apoptosis was identified by the typical morphological characteristics such as cell shrinkage, rounding deposition of filaments and detachment from the substratum (Figure 1 ). DNA of TNFa treated cells was fragmented to the characteristic ladder of 180 ± 200 base pairs and multiples thereof (Figure 2 ). Moreover, signature type cleavage of poly(ADP-ribose) polymerase (PARP) into a 89 kDa peptide (Tewari et al, 1995) showed activation of apoptosis-specific proteolysis upon exposure to TNFa ( Figure  3 ).
Expression of c-myc, cdc25A, cyclin D1, gas6 and Cdk2 kinase activity It has been shown previously, that TNFa-induced apoptosis required c-Myc expression (Klefstrom et al, 1994; Janike et al, 1994) . We found that during TNFa-induced apoptosis of N.1 cells c-Myc protein was constitutively expressed (Figure 4) . Although it has been reported by Galaktionov et al (1996) that cdc25A is a target of the transcription factor c-Myc in Myc-ER cells, in N.1 cells cdc25A transcript levels decreased after 24 h of TNFa treatment, despite unchanged c-Myc expression ( Figure 5A ). Cdc25A protein levels also markedly dropped after 48 h of TNFa treatment ( Figure 6 ). Down-regulation of Cdc25A during TNFa-induced apoptosis was surprising since it has been shown that apoptosis of Myc-ER cells entirely depended on Cdc25A expression, and inhibition of Cdc25A expression did not permit active cell death (Galaktionov et al, 1996) .
It is well known that Cdc25A regulates Cdk2 kinase activity (Morgan, 1995; Hofmann et al, 1994) . Therefore, we measured Cdk2 kinase activity in a Cdk2-immunocomplex assay Perez-Roger et al, 1997; Rudolph et al, 1996) after treatment of N.1 cells with 20 ng/ml TNFa for 72 h. Cdk2 assays were repeated three times with only small differences. A representative experiment in which 20 ng/ml TNFa was applied to N.1 cells for 72 h is shown in Figure 7 . When compared to untreated control cells Cdk2 activity became down-regulated during TNFa treatment Figure  6 ). To examine if Cdc25A and Cdk2 down-regulation was due to a TNFa induced arrest in G 0 , the expression of cyclinD1 (down-regulated in G 0 : Motokura and Arnold, 1993; Draetta, 1994; Pusch et al, 1996) and gas6 (upregulated in G 0 ; Schneider et al, 1988; Manfioletti et al, 1993) , was analyzed. Cyclin D1 expression was not inhibited nor was gas6 expression induced after treatment with 20 ng/ml TNFa within 72 h ( Figure 5B ).
Inhibition of apoptosis correlates with c-myc repression
When N.1 cells were treated with genistein, TNFa-induced apoptosis was abrogated ( Figure 8 shows genisteinpretreated N.1 cells which were exposed to 20 ng/ml TNFa for 72 h). As a control N.1 cells were also exposed to the kinase inhibitors Ckl-7 and H-89, which did not inhibit TNFainduced apoptosis (data not shown).
To examine whether TNFa-induced apoptosis of N.1 correlated with c-myc expression as previously demonstrated in Rat1, NIH3T3 and HeLa cells (Klefstrom et al, 1994; Janicke et al, 1994) , the expression of c-myc was analyzed. In the presence of genistein the constitutive level of c-myc was reduced down to the limits of detection ( Figure 9A , lane 3). cdc25A mRNA was also efficiently down-regulated upon genistein treatment Kinetics of cdc25A, cyclin D1 and gas6 mRNA expression. N.1 cells were treated for 2, 6, 24, 48 and 72 h with 20 ng/ml TNFa (lanes 2 ± 6, respectively). Lane 1 shows an untreated control. Filters were hybridized with a cdc25A probe (A), stripped and reprobed with cyclin D1 and gas6 together (B), stripped and reprobed with GAPDH (C) Figure 6 Kinetics of Cdc25A protein expression. N.1 cells were treated for 2, 6, 24, 48 and 72 h with 20 ng/ml TNFa (lanes 2 ± 6, respectively). Lane 1 shows an untreated control. Protein was extracted, separated on SDS ± PAGE, transferred to nitrocellulose and immunoblotted with polyclonal anti-Cdc25A antibody ( Figure 9B ; compare lane 1 versus lanes 3 and 4). The levels of the repressed cdc25A transcripts were almost the same, regardless of whether N.1 cells were exposed to TNFa+genistein (lane 4), or to genistein alone (lane 3).
In experiments in which N.1 cells were exposed to kinase inhibitors Ckl-7 and H-89 in presence of TNFa (Figure 9A ,B; lanes [+] ) for 15 h the epxression of c-myc and cdc25A was found to be only marginally affected. When cells were incubated for 15 h with inhibitors alone (Figure 9A ,B; lanes [7] ), no significant differences of Ckl-7 and H-89 expression to control experiments were observed.
In accordance with the suggested role of high c-myc expression in inducing apoptosis, only treatment with genistein which inhibited TNFa-mediated apoptosis ( Figure  8 ) also down-regulated c-Myc. Ckl-7 and H-89, which did not inhibit TNFa induced apoptosis had no significant effect on c-myc expression. This experiment further shows that down-regulation of cdc25A does not induce apoptosis because it is also down-regulated during genistein treatment.
Discussion
TNFs induced apoptosis in various different cell types such as fibroblasts, hepatocytes, endothelial-, fibrosarcoma-and prostatic carcinoma cells (for review on TNFa mode of action see: Nagata, 1997; Vaux and Strasser, 1996) . Here we show that N.1 ovarian carcinoma cells are also targets of TNFainduced apoptosis.
Biochemical analysis of apoptotic TNFa-stimuli revealed that c-Myc expression remained high and Cdc25A became repressed in N.1 cells. This is contrary to the findings of Figure 7 Cdk2 immunocomplex kinase assay. N.1 cells were exposed to 20 ng/ml TNFa for 72 h (lane to the right). Lane 1 shows an untreated control. Protein was extracted as described under`Materials and Methods'. Cdk2 was immuno-precipitated with monoclonal anti-Cdk2 antibody. For the kinase reaction [
32 Pg]ATP-histone H1 was used as a target. The reaction-mix was terminated by boiling and separated on SDS ± PAGE. Gels were dried and exposed to X-ray films at 7808C Figure 8 Phase-contrast light microphotography of cells treated with genistein and TNFa. N.1. cells were exposed to 100 mM genistein (C) and to a combination of 100 mM genistein+20 ng/ml TNFa (D). A shows untreated control cells and B shows cells which were treated with 20 ng/ml TNFa only. The photos show cells in 100-fold magnification; the scale bar at the lower right corner of D indicates 50 mm Figure 9 Modulation of constitutive and TNFa-induced expression of c-myc and cdc25A, upon simultaneous treatment with individual inhibitors of signal transduction (A and B, respectively). During TNFa treatment (+) and under control conditions (7), inhibitors of signal transduction were co-applied. From left to right: Controls i.e. no inhibitors (lanes 1 and 2); addition of genistein, an inhibitor of tyrosine kinase (lanes 3 and 4); addition of Ckl-7, an inhibitor of casein kinase I (lanes 5 and 6); addition of H-89, an inhibitor of protein kinase A (lanes 7 and 8). After hybridization with cdc25A probe, filters were stripped and rehybridized with c-myc, and finally with GAPDH (C) Galaktionov et al (1996) who showed that apoptosis in 3T3 LI cells dependend entirely on Cdc25A. 3T3 LI cells undergo c-Myc dependent apoptosis under low-serum conditions. When transfected with inducible cdc25A 3T3 LI cells underwent apoptosis only upon induction of cdc25A in low-serum containing medium. Inhibition of endogenous cdc25A expression by incubation of Val5 cells, which is a Myc-ER containing cell line, with an antisense cdc25A oligonucleotide also inhibited b-oestradiol-induced apoptosis (Galaktionov et al, 1996) . Thus, apoptosis of Val5 cells is not only dependent on cdc25A expression, cdc25A would appear to be a functional downstream target of c-Mycinduced apoptosis.
When Myc-ER cells were incubated with cyclohexamide to block protein synthesis b-oestradiol-mediated translocation of Myc-ER induced endogenous cdc25A transcription. Thus, no intermediate protein synthesis was required for cMyc-dependent cdc25A transcription and the conclusion was drawn that cdc25A in an immediate target of the transcription factor c-Myc (Galaktionov et al, 1996) . Indeed, the authors also found c-Myc recognition sequences in introns 1 and 2 of the cdc25A gene.
There would appear to be other factors regulating cdc25A expression since in N.1 cells cdc25A transcription was inhibited despite constitutive c-Myc expression. c-Mycindependent regulation of cdc25A is supported by recent work from Pusch et al (1997) , and also from two other groups who have reported that c-Myc induction did not modulate cdc25A expression (Vlach et al, 1996; PerezRoger et al, 1997 ).
An explanation for this discrepancy could be that apoptotic stimuli might have induced either max and/or mad, thereby competing successfully for Myc-Max heterodimers which represent the activating transcription complex (Amati et al, 1993; Blackwood and Eisenman, 1991) when binding to the cdc25A consensus promoter sequences. Max-Max or Max-Mad complexes would compete with MycMax heterodimers for the same binding sites (Ayer et al, 1993) , which would suppress cdc25A transcription. Alternatively, activity of Cdc25A may be regulated by phosphorylation (Galaktionov et al, 1995) and it is currently unresolved whether apoptosis-related regulation of Cdc25A involves a phosphorylated or de-phosphorylated gene product. Hypothetically overexpression of de-phosphorylated (inactive) Cdc25A protein might act as a dominant negative.
Cdc25A dephosphorylates Cdk2, thereby activating the cyclin E-Cdk2 complex (Morgan, 1995; Hofmann et al, 1994) . As would be expected, TNFa-mediated downregulation of Cdc25A was paralleled by the inhibition of Cdk2 activity as evidenced by histone H1 phosphorylation in an in vitro kinase assay Perez-Roger et al, 1997; Rudolph et al, 1996) .
Despite cdc25A and Cdk2 down-regulation, apoptosis was independent of cell cycle effects as determined by molecular parameters such as cyclin-D1 and gas6 expression. It was shown previously that cyclin-D1 is not expressed in G 0 (Motokura and Arnold, 1993; Draetta, 1994; Pusch et al, 1996) , therefore, the consistent cyclin D1 expression observed shows that the cell cycle was not arrested in G 0 during TNFa-induced apoptosis. Moreover, gas6 which becomes induced in growth arrested cells (Schneider et al, 1988; Manfioletti et al, 1993; Krupitza et al, 1995c) did not become up-regulated at the onset of apoptosis. Therefore, the cdc25A down-regulation by TNFa treatment was related to apoptosis induction but not to G 0 arrest.
As shown for Rat1-, NIH3T3-and HeLa cells (Klefstrom et al, 1994; Janicke et al, 1994) , it seems that N.1 cells also need at least constitutive c-Myc levels for TNFa-induced apoptosis. Arresting cell growth by genistein abrograted TNFa-stimulated apoptosis and c-myc expression (Krupitza et al, 1996) . c-Myc-induced progression from G 0 into G 1 with subsequent inhibition of cycle components such as Cdc25A and Cdk2 might create conditions incompatible with survival. To our knowledge this is the first demonstration that cells can undergo apoptosis in a Cdc25A independent manner.
Materials and Methods
Chemicals and probes
The cDNA of c-myc was a kind gift from Dr. Rainer deMartin, University of Vienna; that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was from Dr. Paul Amstad, University of Maryland; cyclin D1/prad1 from Dr. Johannes Hofmann, IMP Vienna, cdc25A from Dr. David Beach, Howard Hughes Medical Institute, CSH; and gas6 from Dr. Claudio Schneider, ICGEB, Trieste. TNFa was purchased from Gibco (Paisley, UK) and TNFb from RD-systems (Minneapolis, MN). H-89 (specific protein kinase A inhibitor, used at 1 mM final concentration) and Ckl-7 (specific casein kinase 1 inhibitor, used at 10 mM final concentration) came from Seikagaku (Tokyo, Japan) and genistein (an inhibitor of tyrosine kinase activity, used at 100 mM final concentration) from Upstate Biotechnology (Lake Placid, NY), [ 32 Pg]ATP was from Amersham (UK).
Cell culture
The monoclonal human ovarian adenocarcinoma cell line N.1 which is a derivative of the heterogenous cell line HOC-7 (Buick et al, 1985; Grunt et al, 1991) was kept in aMEM supplemented with 10% fetal calf serum (Gibco, Paisley, UK) at 378C in a humidified atmosphere containing 5% CO 2 .
Phase contrast micrographs were taken with a Zeiss MC-80 camera connected to a Zeiss Axiovert inverted-microscope using a TMax black and white print film (Kodak).
Northern blot analysis N.1 cells were grown in T-25 flasks. Experiments were terminated by discarding cell culture supernatants followed by two quick washes with ice cold PBS and subsequent lysis with RNAzol (BioTex, Houston, TX). Total RNA (30 mg/slot) was separated on a 1% agarose gel containing formaldehyde and transferred to Millipore S membranes (Millipore, Bedford, MA) by the capillary method. Biotinylated probes were allowed to hybridize to filter-bound RNA at 678C overnight. Biotinylation procedures and filter processing were done exactly as described previously (Krupitza et al, 1995a) . Filters were then exposed to Kodak X-ray films (Rochester, NY).
DNA analysis
Detached cells were collected from cultures grown in T-25 flasks, centrifuged and lysed in 400 ml of a buffer containing 50 mM Tris pH 8.0, 10 mM EDTA, 0.5% sodium lauryl sarcosine. The majority of the cells, which were still attached (100% in untreated controls) were lysed in the same buffer (1200 ml). 400 ml of both types of lysates (from attached and detached cells) were treated with 2 ml RNAse A (11 U/ml, USB, Cleveland, OH) for 1 h at 378C, followed by the addition of 10 ml of proteinase K (15 mg/ml, Boehringer Mannheim, Germany) and incubation for another 3 h at 508C. Then equal amounts of phenol : chloroform : isoamyl alcohol (25 : 24 : 1, Sigma) were added and DNA extracted by gentle treatment (wide-bore pipets, no vortexing). After two washes with chloroform-isoamyl alcohol (24 : 1), DNA was precipitated with alcohol, and resuspended in 30 ml TE (10 mM Tris, 1 mM EDTA, pH 7.5), 2 ml RNAse (2 U/ml). The lysates derived from attached and detached cells were pooled, the DNA content measured and equal amounts of pooled DNA subjected to electrophoretic separation on 2% agarose gels.
Western blot analysis
Cells from treated and untreated cultures were lysed in SDS sample buffer (25 mM Tris pH 6.8, 3% SDS, 10% glycerol, 36 mM DTT, 0.925 mM EDTA). The amount of protein in each sample was calculated using the dot-metric protein assay kit (Novus Molecular Inc.) and equal amounts of protein were loaded onto 10% polyacrylamide gels. Proteins were electrophoresed at 80 V for 2 ± 3 h and then transblotted onto nitrocellulose membranes at 100 V for 2 h (Towbin et al, 1979) . Membranes were blocked in PBS with 0.5% skimmed milk and 0.05% Tween 20, incubated with primary antibodies (Pan-myc, mouse monoclonal, Genosys Biotechnologies Inc., and Cdc25A rabbit polyclonal, Santa Cruz Biotechnology) overnight, and with horse radish peroxidase conjugated secondary antibody for 2 h. The Amersham ECL kit was used for blot development and chemoluminescence was detected on Kodak Xomat DS films.
Kinase assay
Protein extracts were prepared in a buffer containing 20 mM HEPES pH 7.9, 0.4 M NaCl, 2.5% glycerol, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.5 mM NaF, 0.5 mM Na 3 VO 4 , 0.02 mg/ml leupeptin, 0.02 mg/ml aprotinin, 0.003 mg/ml benzamidinchloride, 0.1 mg/ml trypsin inhibitor and 0.5 mM DTT. After a freeze-thaw cycle in liquid nitrogen, cellular debris was pelleted by centrifugation and supernatant stored at 7708C . Protein concentrations were determined using the BioRad protein assay reagent with bovine serum albumin as standard.
Cyclin-dependent kinase immunoprecipitations and Cdk-analysis was performed according to Soucek et al (1997) . Anti Cdk2 antibody (Santa Cruz) was coupled to protein G-Sepharose beads and incubated with 30 mg protein extract for several hours at 48C. For protein kinase assay these beads were resolved in a mixture containing 50 mM Tris pH 7.4, 10 mM MgCl 2 , 1 mM DTT, 0.2 mM PMSF, 1 mM NaF, 80 mM ATP supplemented with radioactive ATP and 1 mg histone H1. After incubation at 378C for 30 min, proteins were separated by electrophoresis on a 12% SDS-PAA gel. The gel was dried and exposed to X-ray film at 7708C.
